GlassScriptPhysician profile
Andrew Wilson
NPI 1851875173
$14,086.60
in general payments reported to CMS, 2019-2025
19 companies · $171 in 2025
The $171 reported for 2025 was less than what a typical Foot and Ankle Surgery provider received nationally (typical 2025 total: $1,200).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $5,645 · 2020: $2,759 · 2021: $185 · 2022: $168 · 2023: $2,844 · 2024: $2,315 · 2025: $171.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $3,297 · Food and Beverage: $2,033.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $3,297.15 |
| Food and Beverage | $2,032.69 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Supreme Orthopedic Systems, LLC | $7,535.74 | 2019-2021 | |
| Smith+Nephew, INC. | $2,685.73 | 2022-2025 | Oasis, Stravix Pl, Grafix |
| Convatec INC. | $1,852.73 | 2024-2025 | |
| Orthofix Medical, INC. | $726.67 | 2019 | |
| Stryker Corporation | $326.66 | 2019-2021 | |
| Treace Medical Concepts, INC. | $216.37 | 2024-2025 | |
| Aroa Biosurgery Incorporated | $129.21 | 2023 | |
| Ani Pharmaceuticals, INC. | $117.69 | 2025 | Purified Cortrophin Gel |
| Grt US Holding, INC. | $111.02 | 2022 | |
| International Life Sciences | $84.04 | 2024 | Flexband |
| Progenacare Global, LLC | $79.22 | 2023-2024 | |
| Paratek Pharmaceuticals, INC. | $55.82 | 2024 | Nuzyra |
| Averitas Pharma INC. | $36.00 | 2023-2024 | Qutenza |
| Nevro Corp. | $31.94 | 2023 | Senza |
| Amgen INC. | $27.42 | 2024 |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sebela Pharmaceuticals INC. | $23.72 | 2022 | |
| Stability Biologics, LLC | $17.09 | 2024 | |
| Horizon Therapeutics Plc | $14.95 | 2023 | Krystexxa |
| Curonix LLC | $14.58 | 2023 | Pns Freedom-4a Permanent Neurostimulator Receiver Kit Channel A |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Andrew Wilson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.